Core Scientific (CORZ) Net Margin (2021 - 2026)

Core Scientific has disclosed Net Margin across 6 years of filings, most recently posting 301.26% for Q1 2026.

• Net Margin for Q1 2026 came in at 301.26%, down 102588.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 341.68% (down 8073.0% YoY), and the FY2025 annual result was 90.47%, up 19110.0% from the prior year.
• Net Margin came in at 301.26% for Q1 2026 at Core Scientific, down from 270.77% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 724.62% in Q1 2025 to a low of 1191.49% in Q2 2025.
• The 5-year median for Net Margin is 242.16% (2022), against an average of 207.37%.
• Across the five-year window, Net Margin jumped 60710 bps in 2025 and slumped 102588 bps in 2026, its largest moves.
• Core Scientific's Net Margin stood at 358.64% in 2022, then soared by 62 bps to 137.88% in 2023, then plunged by 122 bps to 306.71% in 2024, then surged by 188 bps to 270.77% in 2025, then tumbled by 211 bps to 301.26% in 2026.
• The last three Net Margin figures came in at 301.26% (Q1 2026), 270.77% (Q4 2025), and 177.55% (Q3 2025), per Business Quant data.